Lv4
410 积分 2024-10-15 加入
Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime–Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene
1天前
待确认
In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China
30天前
已完结
Emergence of concurrently transmissible mcr-9 and carbapenemase genes in bloodborne colistin-resistant Enterobacter cloacae complex isolated from ICU patients in Kolkata, India
1个月前
已完结
Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy
1个月前
已完结
Enterobacter hormaechei replaces virulence with carbapenem resistance via porin loss
1个月前
已完结
High-Copy IncP-2 Megaplasmid Carrying blaAFM in Clinical Difficult-to-Treat Resistance Pseudomonas aeruginosa: Associated with High-Level Cefiderocol Resistance
1个月前
已完结
Zidebactam restores cefiderocol sensitivity in resistant bacteria
1个月前
已完结
Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient
1个月前
已完结
In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China
2个月前
已完结
Re: ‘Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates’ by Poirel et al
2个月前
已完结
皖公网安备34019202002308
